v3.26.1
Restatement of Previously Issued Unaudited Condensed Financial Statements - Schedule of Condensed Balance Sheet (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Schedule of Condensed Balance Sheet [Line Items]            
Accounts receivable $ 1,897,383   $ 1,264,805      
Inventory, net 2,099,415   2,226,805      
Total current assets 7,107,445   10,226,284      
Total assets 7,568,605   10,785,647      
Accumulated deficit (82,429,699)   (78,609,787)      
Total stockholders’ equity 5,077,283 $ 6,401,925 7,072,522 $ 1,125,858 $ 2,935,292 $ 822,013
Total liabilities and stockholders’ equity 7,568,605   $ 10,785,647      
As Previously Reported [Member]            
Schedule of Condensed Balance Sheet [Line Items]            
Accounts receivable 2,426,518          
Inventory, net 1,866,633          
Total current assets 7,403,798          
Total assets 7,864,958          
Accumulated deficit (82,133,346)          
Total stockholders’ equity 5,373,636          
Total liabilities and stockholders’ equity 7,864,958          
Adjustment [Member]            
Schedule of Condensed Balance Sheet [Line Items]            
Accounts receivable (529,135)          
Inventory, net 232,782          
Total current assets (296,353)          
Total assets (296,353)          
Accumulated deficit (296,353)          
Total stockholders’ equity (296,353)          
Total liabilities and stockholders’ equity $ (296,353)